男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

血小板因子4(PF4)活性蛋白

Active Platelet Factor 4 (PF4)

CXCL4; SCYB4; Chemokine C-X-C-Motif Ligand 4; Oncostatin-A; Iroplact

  • 血小板因子4(PF4)活性蛋白產(chǎn)品包裝(模擬)
  • 血小板因子4(PF4)活性蛋白產(chǎn)品包裝(模擬)
  • APA172Mu01.pngFigure. SDS-PAGE
  • 血小板因子4(PF4)活性蛋白Sample: Recombinant PF4, Mouse;
    Antibody: Rabbit Anti-Mouse PF4 Ab (PAA172Mu01)
    Figure. Western Blot
  • Certificate通過ISO 9001、ISO 13485質(zhì)量體系認證

活性實驗

Platelet factor 4 (PF4) is a small cytokine belonging to the CXC chemokine family that is also known as chemokine (C-X-C motif) ligand 4 (CXCL4). This chemokine is released from alpha-granules of activated platelets during platelet aggregation, and promotes blood coagulation by moderating the effects of heparin-like molecules. Due to these roles, it is predicted to play a role in wound repair and inflammation. To measure its ability to inhibit the FGF basic-dependent proliferation of HUVEC human umbilical vein endothelial cells, HUVEC cells were seeded into 96-well plates at a density of 3,000 cells/well with 2% serum standard DMEM including 1μg/mL recombinant human FGF1 and various concentrations of recombinant human PF4. After incubated for 48h,?cells were observed by inverted microscope and cell proliferation was measured by Cell Counting Kit-8 (CCK-8). Briefly, 10μL of CCK-8 solution was added to each well of the plate, then the absorbance at 450nm was measured using a microplate reader after incubating the plate for 1-2 hours at 37℃. Proliferation of HUVEC cells after incubation with PF4 for 48h observed by inverted microscope was shown in Figure 1. Cell viability was assessed by CCK-8 (Cell Counting Kit-8) assay after incubation with recombinant human PF4 for 48h. The result was shown in Figure 2. It was obvious that PF4 significantly FGF basic-dependent proliferation of HUVEC cells. The ED50 is 3.4μg/mL.
(A)HUVEC cells cultured in DMEM with 1μg/mL FGF1, stimulated with 5μg/mL PF4 for 48h;
(B) Unstimulated HUVEC cells cultured in DMEM with 1μg/mL FGF1 for 48h.
Figure. Inhibition of HUVEC cells proliferation after stimulated with PF4.

Figure. Inhibition of FGF basic-dependent HUVEC proliferation after stimulated with PF4.

用法

Reconstitute in 20mM Tris, 150mM NaCl (PH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

儲存

避免反復凍融。2-8°C不超過一個月,-80°C不超過12個月。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。

相關產(chǎn)品

編號適用物種:Mus musculus (Mouse,小鼠)應用(僅供研究使用,不用于臨床診斷!)
APA172Mu01血小板因子4(PF4)活性蛋白Cell?culture;?Activity?Assays.
RPA172Mu01血小板因子4(PF4)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA172Mu02血小板因子4(PF4)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAA172Mu01血小板因子4(PF4)多克隆抗體WB; IHC; ICC; IP.
PAA172Mu02血小板因子4(PF4)多克隆抗體WB; IHC; ICC; IP.
LAA172Mu71血小板因子4(PF4)多克隆抗體(生物素標記)WB; IHC; ICC.
LAA172Mu81血小板因子4(PF4)多克隆抗體(異硫氰酸熒光素標記)WB; IHC; ICC; IF.
SEA172Mu血小板因子4(PF4)檢測試劑盒(酶聯(lián)免疫吸附試驗法)Enzyme-linked immunosorbent assay for Antigen Detection.
SCA172Mu血小板因子4(PF4)檢測試劑盒(化學發(fā)光免疫分析法)Chemiluminescent immunoassay for Antigen Detection.
LMA172Mu血小板因子4(PF4)等多因子檢測試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.
KSA172Mu01血小板因子4(PF4)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法)Main materials for "Do It (ELISA Kit) Yourself".

參考文獻

雜志參考文獻
Biochimica et Biophysica Acta (BBA) - Proteins & ProteomicsPropofol lowers serum PF4 level and partially corrects hypercoagulopathy in endotoxemic rats[PubMed: 20601223]
Basic Research in CardiologySecretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation[PubMed: 22899170]
PLoS OnePlatelets Recognize Brain-Specific Glycolipid Structures, Respond to Neurovascular Damage and Promote Neuroinflammation[PubMed: PMC3608633]
Diving and Hyperbaric MedicineEffect of splenectomy on platelet activation and decompression sickness outcome in a rat model of decompression[Pubmed:25311322]
Journal of Functional FoodsA?Phellinus baumii–based supplement containing?Salvia miltiorrhiza?Bunge improves atherothrombotic profiles through endothelial nitric oxide synthase and cyclooxygenase pathwaysin vitro?and?in vivo[science:S1756464616300676]
Plos oneAspirin, but Not Tirofiban Displays Protective Effects in Endotoxin Induced Lung Injury[pubmed:27583400]
international journal of molecular sciences Evidence of the Role of R-Spondin 1 and Its Receptor Lgr4 in the Transmission of Mechanical Stimuli to Biological Signals for Bone Formation.[pubmed:28272338]
Experimental?and?Therapeutic?MedicineFeasibility of improving platelet?rich plasma therapy by using chitosan with high platelet activation ability[pubmed:28450960]
Reproductive ToxicologyAspirin pre-treatment modulates ozone-induced fetal growth restriction and alterations in uterine blood flow in rats[Pubmed: 30528429]
INTERNATIONAL JOURNAL OF CARDIOLOGYShort and long-term changes in platelet and inflammatory biomarkers after cryoballoon and radiofrequency ablation[Pubmed: 30857843]
Available at SSRN 3335365?Evaluating the Platelet Activation Related to the Degradation of Biomaterials by Scheme of Molecular Markers[]
journal of biotechnologyNewly Identified HNP‐F from Human Neutrophil Peptide 1 Promotes Hemostasis[Pubmed: 30927490]
Data in BriefData for short and long-term prothrombotic biomarkers after cryoballoon and radiofrequency ablation[]
journal of thoracic and cardiovascular surgeryEvaluating Platelet Activation Related to the Degradation of Biomaterials Using Molecular Markers[Pubmed: 32812629]
Marine DrugsThe Inhibitory Effect of Protamine on Platelets is Attenuated by Heparin without Inducing Thrombocytopenia in Rodents[Pubmed: 31533230]
Thrombosis ResearchFeasibility study of use of rabbit blood to evaluate platelet activation by medical devices[Pubmed: 31838449]
Nat CommunThe C5a/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets[34099640]
VaccineThe effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats[Pubmed:35183388]